The US-based medical hardware and software company Varian has acquired the Finnish startup Noona, which has developed a cloud-based a communications platform for cancer patients and health centres.

Described in the medical language, Noona is a platform that captures patient-reported outcomes (PROs), which is basically information on how the patient is feeling given by the person themselves.

“PROs represent a growing and significant metric in evidence-based clinical care and translational research,” said Dow Wilson, president and chief executive officer at Varian. “With this acquisition, Varian gains new partnerships with life-sciences and pharma companies as the Noona software app is used to engage patients, collect PRO data, manage patient communications and enable clinical studies that will test the efficacy of treatment modalities when treating cancer.”

Varian is planning to integrate Noona’s solution and technology into its own SaaS suite, 360 Oncology.

Comments are closed.